The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.
D000661:Amphetamine; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D004357:Drug Synergism; D004837:Epinephrine; D008750:Methyldopa / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine; D010293:Pargyline / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology; D014439:Tyramine
D014191:Tranylcypromine; D008750:Methyldopa; D010293:Pargyline; D011335:Proadifen; D000661:Amphetamine; D009526:Nialamide; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine